Related references
Note: Only part of the references are listed.Two Neuroanatomical Signatures in Schizophrenia: Expression Strengths Over the First 2 Years of Treatment and Their Relationships to Neurodevelopmental Compromise and Antipsychotic Treatment
Stefan du Plessis et al.
SCHIZOPHRENIA BULLETIN (2023)
Prospective, randomized, multicenter clinical trial evaluating longitudinal changes in brain function and microstructure in first-episode schizophrenia patients treated with long-acting injectable paliperidone palmitate versus oral antipsychotics
Chencai Wang et al.
SCHIZOPHRENIA RESEARCH (2023)
Effect of treatment with paliperidone palmitate versus oral antipsychotics on frontal lobe intracortical myelin volume in participants with recent-onset schizophrenia: Magnetic resonance imaging results from the DREaM study
T. A. Tishler et al.
SCHIZOPHRENIA RESEARCH (2023)
The Disease Recovery Evaluation and Modification (DREaM) study: Effectiveness of paliperidone palmitate versus oral antipsychotics in patients with recent-onset schizophrenia or schizophreniform disorder
Larry Alphs et al.
SCHIZOPHRENIA RESEARCH (2022)
Neuroimaging Heterogeneity in Psychosis: Neurobiological Underpinnings and Opportunities for Prognostic and Therapeutic Innovation
Aristotle N. Voineskos et al.
BIOLOGICAL PSYCHIATRY (2020)
Association between cortical volume and gray-white matter contrast with second generation antipsychotic medication exposure in first episode male schizophrenia patients
Won Jong Chwa et al.
SCHIZOPHRENIA RESEARCH (2020)
Memory and cognition in schizophrenia
J. Y. Guo et al.
MOLECULAR PSYCHIATRY (2019)
Depth-dependent intracortical myelin organization in the living human brain determined by in vivo ultra-high field magnetic resonance imaging
Emma Sprooten et al.
NEUROIMAGE (2019)
Subcortical structures and cognitive dysfunction in first episode schizophrenia
Fengmei Fan et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2019)
Comprehensive review: Computational modelling of schizophrenia
Vincent Valton et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
White matter connectivity disruptions in early and chronic schizophrenia
M. A. Di Biase et al.
PSYCHOLOGICAL MEDICINE (2017)
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium
T. G. M. van Erp et al.
MOLECULAR PSYCHIATRY (2016)
Increased MRI-based cortical grey/white-matter contrast in sensory and motor regions in schizophrenia and bipolar disorder
K. N. Jorgensen et al.
PSYCHOLOGICAL MEDICINE (2016)
Dose Equivalents for Antipsychotic Drugs: The DDD Method
Stefan Leucht et al.
SCHIZOPHRENIA BULLETIN (2016)
Brain Imaging During the Transition from Psychosis Prodrome to Schizophrenia
Yoonho Chung et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2015)
Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment
Mohamed Ahmed et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Prefrontal cortex and the dysconnectivity hypothesis of schizophrenia
Yuan Zhou et al.
NEUROSCIENCE BULLETIN (2015)
Assessing intracortical myelin in the living human brain using myelinated cortical thickness
Christopher D. Rowley et al.
FRONTIERS IN NEUROSCIENCE (2015)
Cortical Volume, Surface Area, and Thickness in Schizophrenia and Bipolar Disorder
Lars M. Rimol et al.
BIOLOGICAL PSYCHIATRY (2012)
Neuroglialpharmacology: Myelination as a shared mechanism of action of psychotropic treatments
George Bartzokis
NEUROPHARMACOLOGY (2012)
Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia
George Bartzokis et al.
SCHIZOPHRENIA RESEARCH (2012)
Risperidone Nonadherence and Return of Positive Symptoms in the Early Course of Schizophrenia
Kenneth L. Subotnik et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Changes in Cortical Thickness During the Course of Illness in Schizophrenia
Neeltje E. M. van Haren et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Mapping Human Cortical Areas In Vivo Based on Myelin Content as Revealed by T1- and T2-Weighted MRI
Matthew F. Glasser et al.
JOURNAL OF NEUROSCIENCE (2011)
Long acting injection versus oral risperidone in first-episode schizophrenia: Differential impact on white matter myelination trajectory
George Bartzokis et al.
SCHIZOPHRENIA RESEARCH (2011)
Widespread Reductions of Cortical Thickness in Schizophrenia and Spectrum Disorders and Evidence of Heritability
Aaron L. Goldman et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Neurocognition in First-Episode Schizophrenia: A Meta-Analytic Review
Raquelle I. Mesholam-Gately et al.
NEUROPSYCHOLOGY (2009)
In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia
George Bartzokis et al.
SCHIZOPHRENIA RESEARCH (2009)
Neurocognitive functioning in patients with first-episode schizophrenia -: Results of a prospective 5-year follow-up study
Margot Albus et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2006)
Regional deficits in brain volume in schizophrenia: A meta-analysis of voxel-based morphometry studies
R Honea et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Identification of separable cognitive factors in schizophrenia
KH Nuechterlein et al.
SCHIZOPHRENIA RESEARCH (2004)
Thinning of the cerebral cortex in aging
DH Salat et al.
CEREBRAL CORTEX (2004)
Schizophrenia: Breakdown in the well-regulated lifelong development and
G Bartzokis
NEUROPSYCHOPHARMACOLOGY (2002)
The early stages of schizophrenia: Speculations on pathogenesis, pathophysiology, and therapeutic approaches
JA Lieberman et al.
BIOLOGICAL PSYCHIATRY (2001)
Measuring the thickness of the human cerebral cortex from magnetic resonance images
B Fischl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)